Literature DB >> 9708814

Extrahepatic expression and regulation of protein C in the mouse.

K Yamamoto1, D J Loskutoff.   

Abstract

Activated protein C (APC) acts as an anticoagulant by inhibiting coagulation factors Va and VIIIa. Although the liver appears to be the primary site of protein C (PC) synthesis, the demonstration that other components of this system are produced extrahepatically raises the possibility that PC itself is synthesized in other tissues. We therefore used quantitative reverse transcription-polymerase chain reaction, in situ hybridization, and immunohistochemistry to screen various murine tissues for PC expression. Relatively high levels of PC mRNA were detected in the kidney (35% of liver) and testis (22% of liver). PC mRNA and antigen were demonstrated in tubular epithelial cells in the renal cortex, in spermatogenic cells in the testis, and in epithelial cells in the epididymis. Low but significant levels of PC mRNA were detected in the epididymis (1.7% of the level in liver), brain (1.1% of liver), and lung (0.8% of liver). PC antigen was demonstrated in bronchial epithelial cells in the lung, in pyramidal neurons in the cerebrum, and in Purkinje cells in the cerebellum. The extrahepatic expression of PC mRNA (ie, in the kidney) was significantly decreased in mice with renal disease (eg, in MRL lpr/lpr mice with autoimmune lupus nephritis, in db/db mice with diabetic nephropathy, and in endotoxin-treated mice with acute renal injury). The decreased renal expression of PC may contribute to the increased procoagulant potential of the kidney during septic and inflammatory processes and to the progression of kidney disease associated with these conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708814      PMCID: PMC1852986          DOI: 10.1016/S0002-9440(10)65597-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA.

Authors:  K Tokunaga; H Taniguchi; K Yoda; M Shimizu; S Sakiyama
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

2.  Studies with the mutation, diabetes, in the mouse.

Authors:  D L Coleman; K P Hummel
Journal:  Diabetologia       Date:  1967-04       Impact factor: 10.122

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  Prothrombin mRNA is expressed by cells of the nervous system.

Authors:  M Dihanich; M Kaser; E Reinhard; D Cunningham; D Monard
Journal:  Neuron       Date:  1991-04       Impact factor: 17.173

5.  Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria.

Authors:  F G Cosio; C Harker; M A Batard; J T Brandt; J H Griffin
Journal:  J Lab Clin Med       Date:  1985-08

6.  Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn.

Authors:  U Seligsohn; A Berger; M Abend; L Rubin; D Attias; A Zivelin; S I Rapaport
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

7.  Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.

Authors:  A P Sappino; J Huarte; J D Vassalli; D Belin
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

8.  Effects of fibrinogen degradation products on glomerular mesangial cells in culture.

Authors:  T Tsumagari; K Tanaka
Journal:  Kidney Int       Date:  1984-11       Impact factor: 10.612

9.  The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs.

Authors:  R J Beckmann; R J Schmidt; R F Santerre; J Plutzky; G R Crabtree; G L Long
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

10.  Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.

Authors:  V W van Hinsbergh; R M Bertina; A van Wijngaarden; N H van Tilburg; J J Emeis; F Haverkate
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

View more
  12 in total

1.  Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury.

Authors:  Marcus J Schultz; Marcel Levi
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

Review 2.  The protein C pathway and pathologic processes.

Authors:  F J Castellino; V A Ploplis
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

Review 3.  Cytoprotective protein C pathways and implications for stroke and neurological disorders.

Authors:  Berislav V Zlokovic; John H Griffin
Journal:  Trends Neurosci       Date:  2011-02-25       Impact factor: 13.837

4.  Potentiation of NMDA receptor function by the serine protease thrombin.

Authors:  M B Gingrich; C E Junge; P Lyuboslavsky; S F Traynelis
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 5.  Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Nicole Ziliotto; Francesco Bernardi; Fabrizio Piazza
Journal:  Neurol Sci       Date:  2021-05-27       Impact factor: 3.307

Review 6.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

7.  Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder.

Authors:  WooJin Kim; Erin Zekas; Robert Lodge; Delia Susan-Resiga; Edwidge Marcinkiewicz; Rachid Essalmani; Koichiro Mihara; Rithwik Ramachandran; Eugene Asahchop; Benjamin Gelman; Éric A Cohen; Christopher Power; Morley D Hollenberg; Nabil G Seidah
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

Review 8.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

9.  Biologically active ADAMTS13 is expressed in renal tubular epithelial cells.

Authors:  Minola Manea; Ramesh Tati; Jessica Karlsson; Zivile D Békássy; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

10.  Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrier.

Authors:  Rashid Deane; Barbra LaRue; Abhay P Sagare; Francis J Castellino; Zhihui Zhong; Berislav V Zlokovic
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-08       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.